Warning: Declaration of My_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $data_object, $depth = 0, $args = NULL, $current_object_id = 0) in /home2/ajnrblog/public_html/ajnrdigest/wp-content/themes/ajnr/functions.php on line 258
Abnormal Cerebral Microstructure in Premature Neonates with Congenital Heart Disease - AJNR News Digest
February 2013
Pediatrics

Abnormal Cerebral Microstructure in Premature Neonates with Congenital Heart Disease

Lisa Paquette

Lisa Paquette

Jessica Wisnowski

Jessica Wisnowski

Multiple prior studies of term neonates with congenital heart disease (CHD) have documented delayed brain maturation (both in utero and in the preoperative postnatal period), particularly in term infants with single ventricle physiology, further increasing their risk for injury or adverse neurodevelopmental outcome. In contrast, very few studies exist of preterm neonates with congenital heart disease.  Prematurity and congenital heart disease are independent risk factors for adverse neurodevelopmental outcome, and it follows that having both further increases the risk.  In our paper we examined the cerebral microstructure of preterm infants with CHD in relation to prematurity and injury, hoping to gain insights into the complex combination of risks portending adverse neurodevelopment in infants with CHD. We found that diffuse microstructural abnormalities are seen in preterm neonates with congenital heart disease when compared with term neonatal controls without CHD.  When we removed the cases of preterm CHD that demonstrated punctate white matter lesions (a current imaging correlate of periventricular leukomalacia), microstructural abnormalities remained in the splenium of the corpus callosum, a structure involved in mediating visual-spatial function. In contrast, there was very little difference in microstructure between the preterm CHD group and preterm neonates without CHD.

Our study is unique, as it is one of the first to use tract-based spatial statistics (TBSS) to analyze diffusion tensor imaging data from neonates with CHD. We did methodological validation of the TBSS technique by also performing comparative manual region-of-interest (ROI) diffusion tensor quantitative metric measurements, and delineated comparable results.

We also found interesting correlations between the occurrence of punctate white matter lesions and certain clinical and perioperative variables  (use of inotropes and age at surgery).  We are in the midst of a longitudinal study design in which the neonates in our study are being recruited back at older ages for neurocognitive assessments and repeat neuroimaging.

Our multidisciplinary, multisited research group is committed to studying mechanisms of aberrant brain development and brain injury in neonates with different forms of CHD.  Our group has expanded so that we are now obtaining innovative physiological cerebral optical imaging data and unique neurodevelopmental outcome measures that can be correlated with our advanced neuroimaging findings. Upcoming studies include: 1) evaluating the use of functional connectivity to study postnatal brain develop and predict outcomes in CHD patients, 2) studying aberrant serial brain development with advanced imaging techniques from the fetal to the neonatal period in CHD patients, and 3) comparing advanced neuroimaging findings between preterm and term neonates with CHD.

Lisa Paquette and Jessica Wisnowski, co-first authors

 
Read this article at AJNR.org . . .